Related Experiment Video
Updated: Aug 14, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Human Cytomegalovirus Suppresses Estrogen and Progesterone Receptor Expression in Hormone Receptor-Positive Breast
Erica C Garcia1,2, Ian J LaRue1, Nathan D Griggs1
1Division of Biology, Texas Woman's University, Denton, TX 76204, USA.
Background:
Hormone receptor-positive breast cancer depends on estrogen and progesterone signaling, yet factors that modulate hormone receptor expression within tumors remain incompletely understood. Human cytomegalovirus (HCMV), a widespread herpesvirus detected in breast tumors, has been associated with reduced expression of estrogen receptor-α (ERα) and progesterone receptor (PR), but a direct causal relationship has not been established.
Methods:
ER+/PR+ breast cancer cell lines MCF-7 and T47D were infected with HCMV in vitro. ERα and PR protein levels were assessed by immunoblotting, and transcript levels of ESR1 and PGR were quantified by qPCR. To determine whether virus replication was required, parallel experiments used UV-inactivated HCMV.
Results:
HCMV infection resulted in a marked reduction in ERα and PR protein levels in both cell lines, accompanied by decreased ESR1 and PGR transcript levels by 48 h post-infection. Notably, UV-inactivated HCMV produced a comparable suppression of hormone receptor expression, indicating that viral gene expression and productive replication are not required for this effect.
Conclusions:
These findings indicate that HCMV exposure suppresses ERα and PR expression in breast cancer cells through a replication-independent mechanism. This effect suggests that viral components or host responses to infection may alter hormone receptor signaling within tumors, with potential implications for hormone receptor signaling and endocrine therapy responsiveness that warrant further investigation. Together, these results identify HCMV as a previously underrecognized modulator of hormone receptor pathways in breast cancer.
Insights
Human cytomegalovirus (HCMV) exposure reduces estrogen receptor-alpha (ERα) and progesterone receptor (PR) in breast cancer cells. This effect occurs independently of viral replication, suggesting HCMV influences hormone signaling pathways.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- Hormone receptor-positive breast cancer relies on estrogen and progesterone signaling.
- Factors influencing hormone receptor expression in tumors are not fully understood.
- Human cytomegalovirus (HCMV) is found in breast tumors and linked to reduced ERα and PR, but causality is unproven.
Purpose of the Study:
- To investigate the causal relationship between HCMV infection and hormone receptor expression in breast cancer.
- To determine if viral replication is necessary for HCMV to affect ERα and PR levels.
Main Methods:
- Infection of ER+/PR+ breast cancer cell lines (MCF-7, T47D) with HCMV in vitro.
- Assessment of ERα and PR protein levels via immunoblotting.
- Quantification of ESR1 and PGR transcript levels using qPCR.
- Use of UV-inactivated HCMV to test the role of viral replication.
Main Results:
- HCMV infection significantly reduced ERα and PR protein levels in both cell lines.
- Decreased ESR1 and PGR transcript levels were observed 48 hours post-infection.
- UV-inactivated HCMV caused similar suppression, indicating viral replication is not required.
Conclusions:
- HCMV exposure suppresses ERα and PR expression in breast cancer cells via a replication-independent mechanism.
- Viral components or host responses to HCMV may alter tumor hormone receptor signaling.
- HCMV is identified as a potential modulator of hormone receptor pathways in breast cancer, impacting endocrine therapy responsiveness.
Related Concept Videos
Mitogens and the Cell Cycle
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Cytomegalovirus Disease
